Saeidreza Jamalimoghadamsiahkali
Overview
Explore the profile of Saeidreza Jamalimoghadamsiahkali including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
530
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siami Z, Rasooli A, Zebardast J, Jalali I, Jamalimoghadamsiahkali S
Health Sci Rep
. 2024 Jul;
7(7):e2252.
PMID: 39044845
Introduction: This retrospective cross-sectional study aimed to assess the outcomes of Covid-19 patients who received remdesivir therapy at the outpatient department of Ziaian Hospital. Method: A total of 514 eligible...
2.
Bayrami S, Chamani M, Jamalimoghadamsiahkali S, SeyedAlinaghi S, Shirmard L, Bayrami S, et al.
J Pharm Sci
. 2024 Mar;
113(8):2552-2559.
PMID: 38508339
Purpose: In the present study, biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles (NPs) containing insulin were loaded in sodium alginate/jeffamine (ALG/jeff) hydrogel for prolonged delivery of insulin. The main aim of this...
3.
Alipour R, Jamalimoghadamsiahkali S, Karimi M, Asadi A, Ghaem H, Adel-Mehraban M, et al.
Integr Med Res
. 2022 Nov;
11(4):100898.
PMID: 36337766
Background: Non-pharmacological strategies that have been proposed by complementary medical systems, can be effective in management of COVID-19. Methods: This study was designed as a three-arm, assessor-blinded, randomized controlled trial....
4.
Siami Z, Jamalimoghadamsiahkali S, Khavandegar A
Clin Case Rep
. 2022 Jul;
10(7):e6113.
PMID: 35903512
The COVID-19 gold standard assessment tool remained the RT-PCR of upper respiratory tract specimen extracted by the nasopharyngeal swab. A positive result would decrease through a three-week course and eventually...
5.
Singh B, Lant S, Cividini S, Cattrall J, Goodwin L, Benjamin L, et al.
PLoS One
. 2022 Jun;
17(6):e0263595.
PMID: 35653330
Background: Neurological COVID-19 disease has been reported widely, but published studies often lack information on neurological outcomes and prognostic risk factors. We aimed to describe the spectrum of neurological disease...
6.
Honarkar Shafie E, Taheri F, Alijani N, Okhovvat A, Goudarzi R, Borumandnia N, et al.
Phytother Res
. 2022 Jan;
36(2):1013-1022.
PMID: 35023260
It has been more than a year since the outbreak of COVID-19, and it is still the most critical issue of the healthcare system. Discovering effective strategies to treat infected...
7.
Maghbooli Z, Sahraian M, Jamalimoghadamsiahkali S, Asadi A, Zarei A, Zendehdel A, et al.
Endocr Pract
. 2021 Oct;
27(12):1242-1251.
PMID: 34653608
Objective: The goal of this randomized, double-blinded, placebo-controlled clinical trial was to investigate the therapeutic efficacy of oral 25-hydroxyvitamin D (25(OH)D) in improving vitamin D status in vitamin D-deficient/vitamin D-insufficient...
8.
Karimi M, Zarei A, Soleymani S, Jamalimoghadamsiahkali S, Asadi A, Shati M, et al.
Phytother Res
. 2021 Oct;
35(11):6295-6309.
PMID: 34606123
Persian medicine has recommended clinical experiences and proper herbal remedies for prevention and treatment of microbial infections and respiratory diseases. An open-label, randomized, controlled, multicenter trial was conducted at five...
9.
Jamalimoghadamsiahkali S, Zarezade B, Koolaji S, SeyedAlinaghi S, Zendehdel A, Tabarestani M, et al.
Eur J Med Res
. 2021 Feb;
26(1):20.
PMID: 33573699
Background: Vitamin C is an essential water-soluble nutrient that functions as a key antioxidant and has been proven to be effective for boosting immunity. In this study, we aimed to...
10.
Edalatifard M, Akhtari M, Salehi M, Naderi Z, Jamshidi A, Mostafaei S, et al.
Eur Respir J
. 2020 Sep;
56(6).
PMID: 32943404
Introduction: There are no determined treatment agents for severe COVID-19. It is suggested that methylprednisolone, as an immunosuppressive treatment, can reduce the inflammation of the respiratory system in COVID-19 patients....